PGP and osteosarcoma: The cyclosporine analogue PSC833 (Valspodar®) proved effective in overcoming P-gp mediated doxorubicin resistance in vitro (human osteosarcoma cell line) and was subsequently used in dogs with osteosarcoma [157].